Safely Transition Patients on Chronic Immune Thrombocytopenia Meds at Home

The new med fostamatinib (Tavalisse, TAV-ah-lees) will lead to questions about CHRONIC treatment of immune thrombocytopenia (ITP).

We're familiar with treating most patients with acute ITP using high-dose steroids...IVIG...or both.

If thrombocytopenia persists, splenectomy is typically the next step. But newer data support trying chronic ITP meds first.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals